BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

BioXcel Therapeutics

BioXcel Therapeutics logo

Founded
2017
Geography
United States of America based
Funding
$69 M

BioXcel Therapeutics is a clinical stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

BXCL501
Clinical  |  Visit website

BXCL501 is an investigational sublingual thin film formulation of dexmedetomidine in development for acute treatment of agitation in multiple neuropsychiatric indications.

BXCL701
Clinical  |  Visit website

BXCL701 is an investigational orally-available systemic innate immunity activator in development for the treatment of a rare form of prostate cancer and for the treatment of pancreatic cancer.

Products

 

Services

No services posted yet